Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 22, 2010

Premium

Scott Greer has been appointed chairman of the board of directors of Ablexis, an antibody technology company.

Greer founded and served as CEO and later as chairman of the board of Abgenix, until its acquisition by Amgen in 2006. He also served as chairman of the board of Sirna Therapeutics before its $1.1 billion acquisition by Merck in 2007. In the past, Greer has served on several other boards, including Affymax and Illumina. He is currently the managing director of Numenor Ventures.


Sequenom has elected several members to its board of directors who will serve until 2011, including: Ernst-Günter Afting; Kenneth Buechler; John Fazio; Harry Hixson; Richard Lerner; Ronald Lindsay; and David Pendarvis.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.